XML 73 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
5 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2012
Dec. 31, 2012
Sep. 30, 2013
Cash flows from operating activities:      
Net income (loss) $ 3,441,901 $ 4,819,306 $ (7,516,074)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Amortization/accretion of available-for-sale securities premiums and discounts, net (135,362) (347,647) (907,795)
Realized loss on sale of investments, net 21,362 98,382 33,708,977
Unrealized (gain) loss on Linked Transactions, net (3,247,461) (3,932,369) 1,940,336
Realized (gain) loss on derivative contracts 21,333 37,333 (19,466,902)
Unrealized loss on derivative contracts 298,959 298,359 3,174,076
Net change in:      
Deferred offering costs (762,166)   0
Accrued interest receivable (185,747) (189,364) (820,324)
Other assets 0   (143,978)
Paydown receivable 0   (238,679)
Accrued interest payable 33,251 65,820 42,347
Paydown payable 270,609   0
Fees and expenses payable to Manager 132,721 32,721 305,000
Other accounts payable and accrued expenses 789,325 4,990 235,316
Net cash provided by operating activities 678,725 887,531 10,312,300
Cash flows from investing activities:      
Purchase of available-for-sale securities (78,095,506) (81,162,110) (1,084,963,739)
Proceeds from sales of available-for-sale securities 0   678,644,658
Purchase of derivative contracts (64,000) (64,000) (50,816,532)
Proceeds from sales of derivative contracts 0   69,806,101
Principal payments from available-for-sale securities 823,106 2,817,375 27,053,462
Restricted cash (496,439) (1,933,390) (11,758,268)
Net cash used in investing activities (77,832,839) (80,342,125) (372,034,318)
Cash flows from financing activities:      
Net proceeds from issuance of common stock 26,177,089 26,177,089 84,000,000
Net proceeds from issuance of preferred stock 0   10,041
Redemption of preferred stock 0   (110,000)
Restricted stock compensation expense 0   89,193
Change in deferred offering costs 0 (915,512) 915,512
Dividends paid on common stock 0 (940,839) (7,532,736)
Dividends paid on preferred stock 0   (2,326)
Proceeds from repurchase agreements 262,703,000 392,314,000 3,332,278,000
Principal repayments of repurchase agreements (199,074,000) (328,891,000) (3,018,657,000)
Net cash paid on securities underlying Linked Transactions (19,392,902) (18,669,385) (45,091,937)
Cash received from repurchase agreements underlying Linked Transactions 13,149,000 13,989,000 28,559,000
Net cash provided by financing activities 83,562,187 83,063,353 374,457,747
Net increase in cash and cash equivalents 6,408,073   12,735,729
Cash and cash equivalents, beginning of period 0 0 3,608,759
Cash and cash equivalents, end of period 6,408,073 3,608,759 16,344,488
Supplemental disclosure of cash flow information      
Cash paid for interest 184,056 201,260 4,079,232
Non-cash investing and financing activities information      
Dividends declared but not paid at end of period 0 220,833 2,326
Net change in unrealized gain (loss) on available-for-sale securities $ 3,008,004 $ 2,433,997 $ (9,939,532)